Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics.

Yadav, Manoj Kumar; Kumari, Indu; Singh, Bijender; Sharma, Krishna Kant; Tiwari, Santosh Kumar

Yadav, Manoj Kumar; Kumari, Indu; Singh, Bijender; Sharma, Krishna Kant; Tiwari, Santosh Kumar.

Afiliación

Yadav MK; Department of Genetics, Maharshi Dayanand University, Rohtak, 124001, Haryana, India.
Kumari I; Department of Genetics, Maharshi Dayanand University, Rohtak, 124001, Haryana, India.
Singh B; Department of Microbiology, Maharshi Dayanand University, Rohtak, 124001, Haryana, India.
Sharma KK; Department of Biotechnology, Central University of Haryana, Jant-Pali 123031, Mahendragarh, Haryana, India.
Tiwari SK; Department of Microbiology, Maharshi Dayanand University, Rohtak, 124001, Haryana, India.

Appl Microbiol Biotechnol ; 106(2): 505-521, 2022 Jan.

Article en En | MEDLINE | ID: mdl-35015145

Asunto(s)

Microbioma Gastrointestinal; Enfermedades Inflamatorias del Intestino; Probióticos; Simbióticos; Humanos; Prebióticos

Palabras clave

Chronic diseases; Human health; Prebiotics; Probiotics; Synbiotics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Probióticos / Simbióticos / Microbioma Gastrointestinal Límite: Humans Idioma: En Revista: Appl Microbiol Biotechnol Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google